Fever of Unknown Origin: The Journal of The Association of Physicians of India May 2004
Fever of Unknown Origin: The Journal of The Association of Physicians of India May 2004
Fever of Unknown Origin: The Journal of The Association of Physicians of India May 2004
net/publication/8095643
CITATIONS READS
2 2,976
2 authors, including:
Atul Gogia
Sir Ganga Ram Hospital
70 PUBLICATIONS 137 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Unusual complication of prolonged indwelling urinary catheter ‑ iatrogenic hypospadias View project
All content following this page was uploaded by Atul Gogia on 21 May 2014.
• Allergic - Milk protein allergy, hypersensitivity *Includes tuebrculosis, histoplasmosis, coccidioidomycosis, sarcoidosis
penumonitis, extrinsic allergic alveolitis, metal fume fever, and syphilis.
polymer fume fever, idiopathic hypereosinophilic
The initial evaluation of the patient with PUO typically
syndrome.
includes, comprehensive history and physcal examination.
• Nervous system - Complex partial status epilepticus,
Thorough history is important and this should include
cerebrovascular accident, brain tumour, encephalitis.
information about alcohol intake, medications, occupational
• Others - Anomalous thoracic duct, psychogenic fever, exposures, pets, travel, familial disorders and previous
habitual hyperthermia, factitious illness, shunt nephritis, illnesses. The specific findings that have led to a diagnosis
malacolapkia, Kawasaki’s syndrome, Kikuchi’s syndrome, in FUO are numerous and diverse. The yield of physical
mesenteric fibromatosis, inflammatory pseudotumour examination is not recorded in most studies of FUO. The
Castleman’s disease, Vogt-Koyanagi-Harada syndrome, yield may be high is suggested by two studies reporting that
Graucher’s disease, Schnitzler’s syndrome, FAPA in pediatric patients about 60% had abnormal findings that
syndrome (fever, aphthous stomatitis, pharyngitis, contributed to a diagnosis.19,20 The following table shows
adenitis), Fabry’s disease, cholesterol emboli, silicone how a complete and meticulous physical examination can
embolisation, teflon embolisation, lymph node infarction, lead to a diagnosis.
sickle-cell disease vasoocclusive crisis, anhidrotic
ectodermal dysplasia, cyclic neutropenia, Brewer’s yeast Further in the history careful attention is to be paid to the
ingestion, Hamman-Rich syndrome. host factors.
1. Age
EVALUATION OF PATIENT OF FUO
2. Sex - autoimmune diseases are more common in female,
In FUO, there is no diagnostic gold standard agaisnt which specific disease like pelvic inflammatory disease or male
other diagnostic tests may be measured. Final diagnoses are specific disease like prostatitis.
determined in a number of ways, including a comprehensive
3. Residence present and past - some diseases are more
history, repeated physical examination (Table 3) and a host of
prevalent in a particular area - Kala azar in Bihar.
laboratory investigations.
7. Work environment/home environment. The Duke Specificity 99% Fair Very high
criteria specificity in
8. Drug, underlying disease, cardiac valve disorder, patients with FUO
previous surgeries including splenectomy. Abdominal CT Diagnostic yield 19% Fair High diagnostic
Sensitivity 71% yield
9. Family history of TB or rarely hereditary cause of fever
Specificity 71%
like familial Mediterranean fever should be sought. Tc99m Specificity 93%-94% Fair High Specificity
Clinical features nuclear scan Sensitivity 40%-75% poor sensitivity
Tracer of choice
Fever has been characterized by magnitude and frequency in FUO
and specific fever patterns have been ascribed to many of Gallium 67 Specificity 70%-78% Fair Poor specificity
the causes of FUO.22 Unfortunately in most cases series, the scan Sensitivity 54%-67% and sensitivity
height, pattern or duration of fever did not relate to diagnosis. ESR, C-reactive No evidence to
The response of fever to naproxen sodium may be helpful in protein No study make
MRI, echocardio recommendations
that the fever due to solid tumours and many rheumatological
for or agaisnt it
diseases (most notably Still’s Disease) usually subside Liver biopsy Diagnostic yield Fair High diagnostic
promptly while fever due to other causes may persist.23,24 14%-17% yield and minimal
Laboratory Investigations toxicity
Bone marrow Diagnostic yield Fair Very low
While planning a diagnostic workup for a patient of FUO cultures 0%-20% diagnostic yield
it will be useful to remember that most often the cause of FUO Laparotomy/ Poor High yield in pre-
is a common disorder presenting in atypical rather than an Laparoscopy CT era
exotic disease presenting in its typical form. Empiric No study
Therapy
Diagnostic workup of fever of unknown origin19
A. Comperhensive history
13. Echocardiography in case of cardiac murmur.
B. Physical examination
14. Venous duplex scan of lower limbs.
C. Laboraotry tests (Table 4)
15. Radionuclide scans - Indinium and 67Gallium scans
1. Complete blood count and differential
16. Invasive procedures-
2. Erythrocyte sedimentation rate
Bone marrow aspiration and biopsy (also imprint
3. Blood film reviewed by the hematopathologist smear and culture/serology)
including malarial parasite and malarial serology.
Lymph node FNAC and biopsy
4. Routine blood chemistry (including lactate
dehydrogenase, bilirubin, and liver enzymes) Liver biopsy/thoracoscopy (where indicated)
5. Urinalysis and microscopy Splenic aspirate (where indicated)
6. Blood (x3) and urine cultures (and other sterile CT guided FNAC of mass/lymph node
compartment if clinically indicated e.g. joints pleura, Laparoscopy
CSF) Bronchoscopy and transbronchial biopsy
7. Chest radiogrpah Further evaluation if any abnormalities detected in the
8. Abdominal ultrasonography above tests.
9. Skin Testing-tuberculin skin test Non-invasive test yield diagnosis in about 25% of cases
10. Serology - a) Human immunodeficiency virus, of FUO. Imaging studies have been used to localize
cytomegalovirus IgM antibody; heterophil antibody abnormalities as a preamble to more definitive (invasive)
test (if consistent with mononucleosis - like testing.
syndrome), Q - fever serology (if exposure factor The Duke’s criteria have a very high specificity (99%) in
exist), hepatitis serology (if abnormal liver enzyme patients with FUO and suspected infective endocarditis, and
test result), angiotensin converting enzyme, thus should be used to identify endocarditis as the cause of
b) PCR/NASBA for tuberculosis, hepatitis, CMV. FUO. When the initial investigations are not helpful in
11. Collagen makers - antinuclear antibodies, rheumatoid identifying a cause, the clinician should then proceed to
factors, ENA, pANCA, c ANCA, complement levels. imaging. These should include a CT of the abdomen and a
Technetium based nuclear scan. A CT of the abdomen has a
12. CT abdomen/chest high diagnostic yield (19%)25 and carries a low risk. Two fair-
A fundamental principle in the management of classic FUO 5. Kazanjian PH. Fever of 86 patients treated in community
hospitals. Clin Infect Dis 1992;15:968-73.
is that therapy should be delayed until the cause of fever has
been determined so that the therapy can be tailored to a 6. De Kleijn EM, van der Meer JW. Fever of unknown origin
(FUO): report on 53 patients in a Dutch university hospital.
specific diagnosis. Non-specific treatment is rarely curative
Neth J Med 1995;47:54-60.
and has the potential to delay diagnosis. Non-specific
treatment is rarely curative and has the potential to delay 7. Barbad FJ, Vazquez J. Pyrexia of unknown origin: changing
spectrum of disease in two consecutive series. Postgrad Med
diagnosis. At the same time diagnostic delay adversely affect
J 1992;68:884-87.
the prognosis in intra-abdominal infections, military TB,
8. Larson EB, Featherstone HJ, Petersdorf RG. Fever of
disseminated fungal infection and recurrent pulmonary
undetermined origin: diagnosis and follow up of 105 cases,
embolism. Diagnosis of PUO may require repeated 1970-1980. Medicine (Baltimore) 1982;61:269-92.
examination, interviewing the patient and investigations.
9. Barbado FJ, Vazquez JJ, Pena JM, et al. Fever of unknown
Therapeutic trials origin: a survey on 133 patiens. J Med 1984;15:185-92.
In appropriate clinical settings, therapeutic trials, 10. Deal WB. Fever of unknown origin: analysis of 34 patients.
employing agents with limited spectrum of activity like anti- Postgrad Med 1971;50:182-88.
tubercular drugs may be accepted. It is particularly helpful in 11. De Kleijn EM, Vandenbrouchke JP, van der Meer JW. Fever
cases where there is a history of prolonged low-grade fever of unknown origin (FUO), IA : prospective multicentre study
with evening rise along with raised ESR, a positive tuberculin of 167 patients with FUO using fixed epidemiological criteria.
test with or without loss of appetite and weight. Medicine (Baltimore) 1997;76:392-400.
In suspected temporal arteritis to prevent vascular 12. Knockaert DC, Vanneste LJ, Vanneste SB, Bobaers HJ. Fever
complications like blindness empirical corticosteroids may of unknown origin in the 1980s: an update of the diagnostic
spectrum. Arch Intern Med 1992;152:51-55.
be given.
13. Smith JW. Southwestern Internal Medicine Conference; fever
In other situations empirical treatment with anti- of undetermined origin: not what it used to be. Am J Med Sci
inflammatory agents, aspirin, corticosteroids, antibiotics, or 1986;292:56-64.
anti-neoplastic agents should be desisted.